MA49923A - Système de déciblage de miarn pour interférence spécifique d'un tissu - Google Patents
Système de déciblage de miarn pour interférence spécifique d'un tissuInfo
- Publication number
- MA49923A MA49923A MA049923A MA49923A MA49923A MA 49923 A MA49923 A MA 49923A MA 049923 A MA049923 A MA 049923A MA 49923 A MA49923 A MA 49923A MA 49923 A MA49923 A MA 49923A
- Authority
- MA
- Morocco
- Prior art keywords
- miarn
- screening system
- specific interference
- fabric specific
- fabric
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/50—Biochemical production, i.e. in a transformed host cell
- C12N2330/51—Specially adapted vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762566966P | 2017-10-02 | 2017-10-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA49923A true MA49923A (fr) | 2020-06-24 |
Family
ID=65994761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA049923A MA49923A (fr) | 2017-10-02 | 2018-10-02 | Système de déciblage de miarn pour interférence spécifique d'un tissu |
Country Status (6)
Country | Link |
---|---|
US (1) | US20200248179A1 (fr) |
EP (1) | EP3668997A4 (fr) |
AU (1) | AU2018345772A1 (fr) |
CA (1) | CA3077057A1 (fr) |
MA (1) | MA49923A (fr) |
WO (1) | WO2019070741A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3796919A4 (fr) * | 2018-05-15 | 2022-02-16 | Ramot at Tel-Aviv University Ltd. | Mir126-5p pour le traitement de maladies des motoneurones |
KR20210081324A (ko) | 2018-08-02 | 2021-07-01 | 다인 세라퓨틱스, 인크. | 근육 표적화 복합체 및 안면견갑상완 근육 이영양증을 치료하기 위한 그의 용도 |
CN116096890A (zh) * | 2020-04-02 | 2023-05-09 | 米雷楚莱股份有限公司 | 使用工程化寡核苷酸的靶向抑制 |
JP2023541404A (ja) | 2020-09-11 | 2023-10-02 | アローヘッド ファーマシューティカルズ インコーポレイテッド | DUX4の発現を阻害するためのRNAi剤、その組成物、及び使用方法 |
WO2022147207A1 (fr) * | 2020-12-31 | 2022-07-07 | Dyne Therapeutics, Inc. | Complexes de ciblage musculaire et leurs utilisations pour traiter la myopathie facio-scapulo-humérale |
CA3210662A1 (fr) * | 2021-02-03 | 2022-08-11 | Research Institute At Nationwide Children's Hospital | Compositions et methodes pour traiter une maladie associee a la surexpression de la dux4 |
US11969475B2 (en) | 2021-07-09 | 2024-04-30 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
US11638761B2 (en) | 2021-07-09 | 2023-05-02 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy |
WO2023168202A2 (fr) * | 2022-03-02 | 2023-09-07 | Ultragenyx Pharmaceutical Inc. | Certains inhibiteurs dux4 et leurs procédés d'utilisation |
WO2023196967A1 (fr) * | 2022-04-07 | 2023-10-12 | Kate Therapeutics, Inc. | Compositions et méthodes pour troubles musculaires |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9217155B2 (en) * | 2008-05-28 | 2015-12-22 | University Of Massachusetts | Isolation of novel AAV'S and uses thereof |
US8734809B2 (en) * | 2009-05-28 | 2014-05-27 | University Of Massachusetts | AAV's and uses thereof |
DK2826860T3 (en) * | 2010-04-23 | 2018-12-03 | Univ Massachusetts | CNS targeting AAV vectors and methods for their use |
AU2012286994B2 (en) * | 2011-07-25 | 2017-08-10 | Nationwide Children's Hospital, Inc. | Recombinant virus products and methods for inhibition of expression of DUX4 |
US10975391B2 (en) * | 2014-04-25 | 2021-04-13 | University Of Massachusetts | Recombinant AAV vectors useful for reducing immunity against transgene products |
WO2017173411A1 (fr) * | 2016-04-02 | 2017-10-05 | Research Institute At Nation Wide Children's Hospital | Système promoteur u6 modifié pour l'expression spécifique d'un tissu |
-
2018
- 2018-10-02 EP EP18863924.9A patent/EP3668997A4/fr active Pending
- 2018-10-02 WO PCT/US2018/054005 patent/WO2019070741A1/fr unknown
- 2018-10-02 US US16/651,814 patent/US20200248179A1/en active Pending
- 2018-10-02 CA CA3077057A patent/CA3077057A1/fr active Pending
- 2018-10-02 MA MA049923A patent/MA49923A/fr unknown
- 2018-10-02 AU AU2018345772A patent/AU2018345772A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3668997A1 (fr) | 2020-06-24 |
CA3077057A1 (fr) | 2019-04-11 |
EP3668997A4 (fr) | 2021-05-19 |
AU2018345772A1 (en) | 2020-04-23 |
WO2019070741A1 (fr) | 2019-04-11 |
US20200248179A1 (en) | 2020-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA49923A (fr) | Système de déciblage de miarn pour interférence spécifique d'un tissu | |
CL2018000974S1 (es) | Maquina vibratoria de cribado | |
ZA202001314B (en) | Novel anti-cd3epsilon antibodies | |
MA53218A (fr) | Antagonistes de l'intégrine | |
GB201818634D0 (en) | Language disorder diagnosis/screening | |
MA49642A (fr) | Système de visualisation d'oreille | |
GB2569419B (en) | Improved nonwoven fabric | |
GB202003139D0 (en) | Nonwoven fabric | |
MA44528A (fr) | Système promoteur u6 modifié pour l'expression spécifique d'un tissu | |
GB201707869D0 (en) | Visualisation system for needling | |
CA193447S (en) | Nonwoven fabric | |
FR3031502B1 (fr) | Ensemble de pointage d'un instrument | |
CL2017002523S1 (es) | Material no tejido | |
MA52600A (fr) | Système de suspension de chemisage | |
CL2018003507S1 (es) | Cesto de pantalla de separación. | |
FR3078499B1 (fr) | Machine de dressage de merrains | |
MA44001A (fr) | Machine de criblage | |
GB2594861B (en) | Electrospinning | |
MA50237A (fr) | Système de ruissellement | |
ES1229452Y (es) | Disposición de filtración | |
MC200187B1 (fr) | Système d'attache pour articles de bijouterie | |
CL2019002228S1 (es) | Máquina vibratoria de cribado. | |
GB2580582B (en) | Felting Frame | |
MA52342A (fr) | Système d'ombrage | |
MA52605A (fr) | Produit fibreux |